Intelligent Bio Solutions (INBS) Receivables (2021 - 2025)

Intelligent Bio Solutions has reported Receivables for 5 years, with the latest figure at $1.3 million in Q2 2025.

• For the quarter ending Q2 2025, Receivables rose 200.16% year-over-year to $1.3 million; the trailing twelve-month figure through Jun 2025 stood at $1.3 million (up 200.16% YoY), and the FY2025 full-year result was $1.3 million, up 200.28% from the prior year.
• Receivables for Q2 2025 stood at $1.3 million, up from $1.0 million in the prior quarter.
• The five-year high for Receivables was $3.0 million in Q1 2022, with the low at $442777.0 in Q2 2024.
• Average Receivables over 5 years is $1.4 million, with a median of $1.1 million recorded in 2023.
• Year-over-year, Receivables slumped 79.27% in 2023 and surged 200.16% in 2025.
• Tracing INBS's Receivables over 5 years: stood at $2.8 million in 2021, then dropped by 5.83% to $2.7 million in 2022, then tumbled by 79.27% to $552001.0 in 2023, then rose by 16.26% to $641767.0 in 2024, then soared by 107.09% to $1.3 million in 2025.
• The last three Receivables figures came in at $1.3 million (Q2 2025), $1.0 million (Q1 2025), and $641767.0 (Q4 2024), per Business Quant data.

Peer Comparison